Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

Journal of Hypertension

Volumn 19, Issue 9, 2001, Pages 1553-1558

  Katovich, Michael J ^a   Reaves, Phyllis Y ^b   Francis, Sharon C ^b   Pachori, Alok S ^a   Wang, Hong Wei ^b   Raizada, Mohan K ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT1 receptor; Fructose; Gene therapy; Glucose tolerance; Hypertension; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COMPLEMENTARY DNA; FRUCTOSE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE THERAPY; GLUCOSE INTOLERANCE; HYPERTENSION; INSULIN RESISTANCE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034867361     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200109000-00006     Document Type: Article

References (35)

1. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension
2. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension
3. Insulin resistant in essential hypertension
4. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats
5. Effects of chronic losartan potassium treatment on fructose induced hypertension
6. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance
7. AT1 receptor density changes during development of hypertension in hyperinsulinemic rats
8. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose fed rats and essential hypertensives
9. Fructose-induced insulin resistance and hypertension in rats
10. The tissue renin-angiotensin system in rats with fructose-induced hypertension: Overexpression of type 1 angiotensin II receptor in adipose tissue
11. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat
12. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors
13. Effects of inhibition of the renin angiotensin system on the cardiovascular actions of insulin
14. A comparison of the hypotensive and hypoglycemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone
15. Losartan mediated improvement in insulin action is mainly due to an increase in nonoxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients
16. The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension
17. Role of angiotensin II in fructose induced left ventricular hypertrophy in rats
18. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats
19. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney
20. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology
21. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy
22. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotension type 1 receptor antisense
23. Permanent prevention of hypertension by angiotensin II type 1 receptor antisense gene therapy
24. Losartan versus gene therapy. Chronic control of high blood pressure in spontaneously hypertensive rats
25. 1 receptor antisense
26. 1R) antisense in vitro and in vivo
27. Effect of adrenal demedullation and (or) physical training on glucose tolerance in the rat
28. Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats
29. Fructose feeding in rats is not associated with sodium retention
30. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity
31. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance
32. Influence of blood flow on the fatty acid mobilization from lipolytically active adipose tissue
33. Adrenal medulla as a mediator of diet induced hypertension
34. Cross-talk between the insulin and angiotensin signaling system
35. Inhibition of angiotensin type I receptor prevents decline in glucose transporters in diabetic rat hearts